| Sources | Names Used |
|---|---|
| CTRPv2 | 16-beta-bromoandrosterone |
| PharmacoGx | 16-beta-bromoandrosterone |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SETMAR | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | TRIT1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | TCTEX1D2 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | GZF1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | ZNF500 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | CEBPB | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | SPRTN | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | ZMYND19 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | ATG9A | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | ILF3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
